Guilin Sanjin Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,438.96 million compared to CNY 1,255.65 million a year ago. Net income was CNY 324.38 million compared to CNY 292.9 million a year ago.

Basic earnings per share from continuing operations was CNY 0.5547 compared to CNY 0.5091 a year ago. Diluted earnings per share from continuing operations was CNY 0.5547 compared to CNY 0.5091 a year ago.